134 related articles for article (PubMed ID: 1350077)
1. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
Fink-Jensen A; Judge ME; Hansen JB; Jacobsen P; Turski L; Olney J; Honoré T
Neurosci Lett; 1992 Mar; 137(2):173-7. PubMed ID: 1350077
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
[TBL] [Abstract][Full Text] [Related]
3. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Bhandari P; Andrews PL
Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
6. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
7. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
[TBL] [Abstract][Full Text] [Related]
8. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
9. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
10. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE
J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602
[TBL] [Abstract][Full Text] [Related]
11. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
Ozaki A; Sukamoto T
Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
[TBL] [Abstract][Full Text] [Related]
13. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation.
Sagrada A; Turconi M; Bonali P; Schiantarelli P; Micheletti R; Montagna E; Nicola M; Algate DR; Rimoldi EM; Donetti A
Cancer Chemother Pharmacol; 1991; 28(6):470-4. PubMed ID: 1834359
[TBL] [Abstract][Full Text] [Related]
15. Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets.
Minami M; Endo T; Tamakai H; Ogawa T; Hamaue N; Hirafuji M; Monma Y; Yoshioka M; Hagihara K
Eur J Pharmacol; 1997 Mar; 321(3):333-42. PubMed ID: 9085045
[TBL] [Abstract][Full Text] [Related]
16. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
Maj J; Rogóz Z; Skuza G; Jaros T
Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret.
Lehmann A; Kärrberg L
Neuropharmacology; 1996 Apr; 35(4):475-81. PubMed ID: 8793910
[TBL] [Abstract][Full Text] [Related]
18. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
King GL
J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
[TBL] [Abstract][Full Text] [Related]
19. The actions of fenfluramine and interaction with 5-HT3 receptor-antagonists to inhibit emesis in the ferret.
Costall B; Naylor RJ; Tattersall FD
J Pharm Pharmacol; 1990 Feb; 42(2):94-101. PubMed ID: 1972409
[TBL] [Abstract][Full Text] [Related]
20. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]